Citation Impact
Citing Papers
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
2009 Standout
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Global Histone Modifications in Breast Cancer Correlate with Tumor Phenotypes, Prognostic Factors, and Patient Outcome
2009
Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer
1999 Standout
Untangling the ErbB signalling network
2001 Standout
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
2009 Standout
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement
2015 Standout
Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence
2007 Standout
Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma
2003 StandoutNobel
Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis
2004
Cytoplasmic p21 WAF1/CIP1 expression is correlated with HER-2/ neu in breast cancer and is an independent predictor of prognosis
2003
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer
2007
Triple-Negative Breast Cancer
2010 Standout
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
2014 Standout
Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer
2006 Standout
A gene-expression signature to predict survival in breast cancer across independent data sets
2006
Prognosis and prognostic research: what, why, and how?
2009
QuPath: Open source software for digital pathology image analysis
2017 Standout
Expression of luminal and basal cytokeratins in human breast carcinoma
2004
Breast cancer
2016 Standout
Do we really need prognostic factors for breast cancer?
1994
Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies: The CHARMS Checklist
2014
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
Prognostic factors for survival after breast conserving therapy for stage I and II breast cancer. The role of local recurrence
1995
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Histone methylation: a dynamic mark in health, disease and inheritance
2012 Standout
Pathological prognostic factors in breast cancer. IV: Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma
1995
Histological grading of breast carcinomas: A study of interobserver agreement
1995
The Clinical Utility of Biomarkers in the Management of Pancreatic Adenocarcinoma
2014
An International Ki67 Reproducibility Study
2013
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
2012 StandoutNature
Lymphatic and angiogenic characteristics in breast cancer: morphometric analysis and prognostic implications
2008
The prognostic value of p53 and c-erb b-2 immunostaining is overrated for patients with lymph node negative breast carcinoma
2000
An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer
2010
Pathological prognostic factors in breast cancer
1999 Standout
Biological factors of prognostic significance in locally advanced breast cancer
1994
Prediction of Node-Negative Breast Cancer Outcome by Histologic Grading and S-Phase Analysis by Flow Cytometry
2001
p21 in cancer: intricate networks and multiple activities
2009 Standout
Levels of Hypoxia-Inducible Factor-1 During Breast Carcinogenesis
2001 StandoutNobel
Construction and validation of a prognostic model across several studies, with an application in superficial bladder cancer
2004
p53 protein as a prognostic indicator in breast carcinoma: a comparison of four antibodies for immunohistochemistry
1996
MicroRNA biogenesis pathways in cancer
2015 Standout
An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors
2008 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Assessment and comparison of prognostic classification schemes for survival data
1999
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
2008 Standout
Developing and validating risk prediction models in an individual participant data meta-analysis
2014
Epstein–Barr virus: 40 years on
2004 Standout
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
Positive sentinel node biopsy in male breast carcinoma
2001
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
Proliferation markers and survival in early breast cancer: A systematic review and meta-analysis of 85 studies in 32,825 patients
2008
Calculating the sample size required for developing a clinical prediction model
2020 Standout
Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK
2010
Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond
2009
The molecular landscape of head and neck cancer
2018 Standout
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research
2013
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
2013 Standout
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement
2015 Standout
Prognostic Models: A Methodological Framework and Review of Models for Breast Cancer
2009
Cancer-related inflammation
2008 StandoutNature
Loss of Dicer expression is associated with breast cancer progression and recurrence
2012
Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy
2010
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Expression of Interleukin 11 and Its Receptor and Their Prognostic Value in Human Breast Cancer
2006
The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG)
1994
Adjustment of dendritic cells to the breast-cancer microenvironment is subset specific
2018
Breast cancer metastasis: markers and models
2005 Standout
c-erbB-4 protein expression in human breast cancer
2000
From the immune contexture to the Immunoscore: the role of prognostic and predictive immune markers in cancer
2013
Assessment of Clinical Criteria for Sepsis
2016 Standout
Nomograms to Predict Pathologic Complete Response and Metastasis-Free Survival After Preoperative Chemotherapy for Breast Cancer
2005
Breast Cancer Prognosis Determined by Gene Expression Profiling: A Quantitative Reverse Transcriptase Polymerase Chain Reaction Study
2005
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
2005 Standout
How to Assess Prognostic Models for Survival Data: A Case Study in Oncology
2003
Assessing Bias in Studies of Prognostic Factors
2013 Standout
Local recurrence after simple mastectomy
1994
Reactivity with A monoclonal antibody to Epstein-Barr virus (EBV) nuclear antigen 1 defines a subset of aggressive breast cancers in the absence of the EBV genome.
2003
mice: Multivariate Imputation by Chained Equations inR
2011 Standout
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction
2007 Standout
S-Phase Fraction and Urokinase Plasminogen Activator Are Better Markers for Distant Recurrences Than Nottingham Prognostic Index and Histologic Grade in a Prospective Study of Premenopausal Lymph Node–Negative Breast Cancer
2001
Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis
2006 Standout
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
2005 Standout
Early experience in breast cancer screening: emphasis on development of protocols for triple assessment
1993
Multicenter Validation of a Gene Expression–Based Prognostic Signature in Lymph Node–Negative Primary Breast Cancer
2006
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement
2015 Standout
Metastatic Behavior of Breast Cancer Subtypes
2010 Standout
Strictly Proper Scoring Rules, Prediction, and Estimation
2007 Standout
Tumor-Infiltrating CD8+Lymphocytes Predict Clinical Outcome in Breast Cancer
2011
American Joint Committee on Cancer Prognostic Factors Consensus Conference
1999
Works of Marcus Galea being referenced
The Nottingham prognostic index in primary breast cancer
1992